[en] Rhinosinusitis (RS) is a heterogeneous group of diseases. It is a significant and increasing health problem that affects about 15% of the population in Western countries. It has a substantial impact on patients' health-related quality of life and daily functioning and represents a huge financial burden to society and the health care system as a result of the direct and indirect costs. In addition, RS is not well-understood, and little is known about the etiology and pathophysiology. In the past decade, many papers have been published that have changed our understanding of RS. RS is commonly classified into acute and chronic RS based on symptom duration. In acute RS, an inflammatory reaction initiated by a viral infection characterizes most uncomplicated, mild to moderate cases. Therefore, the first line of treatment for these cases are intranasal steroids and not antibiotics. In severe and complicated cases, antibiotics combined with topical steroids remain the treatment of choice. On the other hand, chronic RS is actually subdivided into two distinct entities (chronic rhinosinusitis with and without polyps), as growing evidence indicates that these entities have specific inflammatory pathways and cytokine profiles. The authors review recent data regarding the clinical presentations, cytokine profiles, tissue remodeling, and modalities of treatment for each form of RS.
Hadley J, Sharp BS, Denman D, Puumala S, Leopold DA. Treatment of acute and chronic rhinosinusitis in the United States, 1999-2002. Arch Otolaryngol Head Neck Surg. 2007;133(3):260-5.
Benson V, Marano MA. Current estimates from the National Health Interview Survey, 1992. Vital Health Stat. 1994;10 (189):1-269.
Bachert C, Meltzer EO. Effect of mometasone furoate nasal spray on quality of life of patients with acute rhinosinusitis. Rhinology. 2007;45:190-6.
Desrosiers M. Diagnosis and management of acute rhinosinusitis. Postgrad Med. 2009;121(3):83-9.
Brook I. Bacteriology of acute and chronic ethmoid sinusitis. J Clin Microbiol. 2005;3(7):3479-80. (Pubitemid 40981371)
PB Van Cauwenberge, Vander Mijnsbrugge AM, Ingels KJAO. The microbiology of acute and chronic sinusits and otitis media: a review. Eur Arch Otorhinolaryngol. 1993;250:S3-6.
Anon JB, Jacobs MR, Poole MD, Ambrose PG, Benninger MS, Hadley JA, Craig WA, Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg. 2004;130(1 Suppl):1-45.
Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol. 2005;116:1289-95. (Pubitemid 41740939)
Meltzer EO, Orgel HA, Backhaus JW, Busse WW, Druce HM, Metzger WJ, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol. 1993;92:812-23. (Pubitemid 23361621)
Barlan IB, Erkan E, Bakir M, Berrak S, Basaran MM. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Ann Allergy Asthma Immunol. 1997;78:598-601. (Pubitemid 27264196)
Dolor RJ, Witsell DL, Hellkamp AS, Williams Jr JW, Califf RM, Simel DL. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. JAMA. 2001;286:3097-105.
Benninger MS, Anon J, Mabry RL. The medical management of rhinosinusitis. Otolaryngol Head Neck Surg. 1997;117(3 pt 2): S41-9.
Benninger MS. Antimicrobial update in rhinology: perspectives from the sinus & allergy health partnership. Symposium held during the 2003 American Rhinologic Society Scientific Meeting, September 20, 2003, Orlando, Florida.
Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61:1280-9. (Pubitemid 44465587)
Bachert C, Gevaert P, Holtappels G, et al. Nasal polyposis: from cytokines to growth. Am J Rhinol. 2000;14:279-90.
Robinson S, Douglas R, Wormald PJ. The relationship between atopy and chronic rhinosinusitis. Am J Rhinol. 2006;20(6):625-8. (Pubitemid 44963827)
Pawankar R. Nasal polyposis: an update. Curr Opin Allergy Clin Immunol. 2003;3:1-6. (Pubitemid 36159341)
Bateman ND, Fahy C, Woolford TJ. Nasal polyps: still more questions than answers. J Laryngol Otol. 2003;117:1-9. (Pubitemid 36084233)
Fokkens W, Lund V, Bachert C, EAACI, et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy. 2005;60:583-601. (Pubitemid 40562464)
Polzehl D, Moeller P, Riechelmann H, Perner S. Distinct features of chronic rhinosinusitis with and without nasal polyps. Allergy. 2006;61:1275-9. (Pubitemid 44465586)
Niederfuhr A, Kirsche H, Riechelmann H, Wellinghausen N. The bacteriology of chronic rhinosinusitis, with and without nasal polyps. Arch Otolaryngol Head Neck Surg. 2009;135(2):131-6.
Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003;129(3 Suppl):S1-32.
Hashemi M, Mir Mohammad Sadeghi M, Omrani MR, Torabi MA. Microbiology and antimicrobial resistance in chronic resistant rhino sinusitis with or without polyp after functional endoscopic sinus surgery. J Res Med Sci (JRMS). 2005;10 (3):167-71. (Pubitemid 41263920)
Kilty SJ, Desrosiers MY. The role of bacterial biofilms and the pathophysiology of chronic rhinosinusitis. Curr Allergy Asthma Rep. 2008;8(3):227-33.
Harvey RJ, Lund VJ. Biofilms and chronic rhinosinusitis: systematic review of evidence, current concepts and directions for research. Rhinology. 2007;45(1):3-13.
Lee JT, Kennedy DW, Palmer JN, Feldman MC, Chiu AG. The incidence of concurrent osteitis in patients with chronic rhinosinusitis: a clinicopathological study. Am J Rhinol. 2006;20(3):278-82. (Pubitemid 44083407)
Perloff JR, Gannon FH, Bolger WE, Montone KT, Orlandi R, Kennedy DW. Bone involvement in sinusitis: an apparent pathway for the spread of disease. Laryngoscope. 2000;110(12):2095-9.
Van Zele T, Gevaert P, Watelet JB, Claeys G, Haoltappels G, Claeys C, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol. 2004;114:981-3. (Pubitemid 39330280)
Ponikau JU, Sherris DA, Kern EB, Homburger HA, et al. The diagnosis and incidence of Allergic Fungal Sinusitis. Mayo Clin Proc. 1999;74:877-84.
Taylor MJ, Ponikau JU, Sherris DA, Kern EB, Gaffey TA, Kephart G, et al. Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein. Otolaryngol Head Neck Surg. 2002;127(5):377-83. (Pubitemid 36547012)
Shin SH, Ponikau JU, Sherris DA, Congdon D, Frigas E, Homburger HA. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol. 2004;114:1369.
Ponikau JU, Sherris DA, Kephart GM, Adolphson C, Kita H. The role of ubiquitous airborne fungi in chronic rhinosinusitis. Curr Allergy Asthma Rep. 2005;5:472-6. (Pubitemid 41683971)
Ponikau JU, Sherris DA, Kita H, Kern EB. Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2002;110(6):862-6. (Pubitemid 36005872)
Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double -blind pilot trial. J Allergy Clin Immunol. 2005;115(1):125-31. (Pubitemid 40075432)
Weschta M, Riechelmann H. Effects of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg. 2006;132(7):743-7. (Pubitemid 44086436)
Kennedy DW, Kuhn FA, Hamilos DL, Zeinreich SJ, Buffler D, Warsi G, et al. Treatment of chronic rhinosinusitis with high dose oral terbinafine: a double blind, placebo controlled study. Laryngoscope. 2005;115(10):1793-9. (Pubitemid 41475891)
Liang KL, Su MC, Shiao JY, Tseng HC, Hsin CH, Lin JF, et al. Amphotericin B irrigation for the treatment of chronic rhinosinusitis without polyps: a randomized, placebo-controlled, double blind study. Am J Rhinol. 2008;22(1):52-8.
Ebbens FA, Georgalas C, Rinia AB, van Drunen CM, Lund VJ, Fokkens WJ. The fungal debate: where do we stand today? Rhinology. 2007;45:178-89.
Schubert MS, Goetz DW. Evaluation and treatment of allergic fungal sinusitis. I. Demographics and diagnosis. J Allergy Clin Immunol. 1998;102:387-94.
Watelet JB, Van Zele T, Gjormarkaj M, Canonica GW, Dahlen SE, Fokkens W, et al. Tissue remodelling in upper airways: where is the link with lower airway remodelling? Allergy. 2006;61(11):1249-58.
Watelet JB, Eloy P, Vancauwenberge P. Drug management in chronic rhinosinusitis: identification of the needs. Ther Clin Risk Manag. 2007;3(1):47-57. (Pubitemid 46671823)
Ponikau JU, Sherris DA, Kephart GM, Kern EB, Gaffrey TA, Tarara BA, et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma? J Allergy Clin Immunol. 2003;112:877-82. (Pubitemid 37412054)
Pawankar R, Nonaka M, Masuno S, Kimura S. Current concepts on the pathomechanisms of chronic rhinosinusitis and nasal polyps. In: Onerci TM, Ferguson BJ, editors. Nasal polyposis: pathogenesis, medical and surgical treatment. New York: Springer; 2010. p. 185-90.
Meltzer EO, Hamilos DL, Hadley JA, Lanza DJ, Marple BF, Nicklas RA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004;114:S155-212.
Watelet JB, Bachert C, Claeys C, Vancauwenberge P. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy. 2004;59:54-60.
Van Bruaene N, Perez-Novo CA, Basinski TM, Van Zele T, Holtappels G, De Ruyck N, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol. 2008;121 (6):1435-41.
Li HB, Cai KM, Liu Z, Xia JH, Zhang Y, Xua R, et al. Foxp3+ T regulatory cells (Tregs) are increased in nasal polyps (NP) after treatment with intranasal steroid. Clin Immunol. 2008;129:394-400.
Eloy P, Watelet JB, Rombaux P, Daele J, Bertrand B. Management of chronic rhinosinusitis without polyps in adults. B-ENT. 2005;(Suppl. 1):65-74, quiz 75-76.
Watelet JB, Eloy P, Van Cauwenberg P. Drug management in chronic rhinosinusitis: identification of the needs. Ther Clin Risk Manag. 2007;3(1):47-57. (Pubitemid 46671823)
Gillespie MB, Osguthorpe JD. Pharmacologic management of chronic rhinosinusitis, alone or with nasal polyposis. Curr Allergy Asthma Rep. 2004;4(6):478-85. (Pubitemid 39585684)
Ulualp SO, Toohill RJ, Hoffmann R, et al. Possible relationship of gastroesophagopharyngeal acid reflux with pathogenesis of chronic sinusitis. Am J Rhinol. 1999;13:197-202.
DiBaise JK, Olusola BF, Huerter JV, et al. Role of GERD in chronic resistant sinusitis: a prospective, open label, pilot trial. Am J Gastroenterol. 2002;97:843-50. (Pubitemid 34408237)
Dinis PB, Monteiro MC, Martins ML, et al. Sinus tissue pharmacokinetics after oral administration of amocicillin/clavulanic acid. Laryngoscope. 2000;110:1050-5. (Pubitemid 30368656)
Passali D, Mazzei T, Novelli A, et al. Amoxicillin/clavulanate in chronic rhinosinusitis: tissue and serum distribution. Acta Otorhinolaryngol Belg. 2001;55:259-64. (Pubitemid 32938777)
Suzuki H, Ikeda K. Mode of action of long-term low-dose macrolide therapy for chronic sinusitis in the light of neutrophil recruitment. Curr Drug Targets Inflamm Allergy. 2002;1:117-26.
Wallwork B, Coman W. Chronic rhinosinusitis and eosinophils: do macrolides have an effect? Curr Opin Otolaryngol Head Neck Surg. 2004;12:14-7.
Taccariello M, Parikh P, Darby Y, et al. Nasal douching in chronic rhinosinusitis: a randomised, single blind study comparing alkaline nasal douche and sterile sea water. Rhinology. 1999;37:29-32.
Keith P, Nieminen J, Hollingworth K, et al. Efficacy and tolerability of fluticasone proprionate nasal drops 400 microgram once daily compared with placebo for the treatment of bilateral polyposis in adults. Clin Exp Allergy. 2000;30:1460-8.
Parikh A, Scadding GK, Darby Y, et al. Topical corticosteroids in chronic rhinosinusitis: a randomized double-blind, placebocontrolled trial using fluticasone proprionate aqueous nasal spray. Rhinology. 2001;39:75-9. (Pubitemid 32631617)
Giger R, Pasche P, Cheseaux C, et al. Comparison of onceversus twice-daily use of beclomethasone diproprionate aqueous nasal spray in the treatment of allergic and non-allergic chronic rhinosinusitis. Eur Arch Otorhinolaryngol. 2003;260:135-40. (Pubitemid 36437750)
Dijkstra MD, Ebbens FA, Poublon RM, et al. Fluticasone proprionate aqueous nasal spray does not influence the recurrence rate of chronic rhinosinusitis and nasal polyps 1 year after functional endoscopic sinus surgery. Clin Exp Allergy. 2004;34:1395-400. (Pubitemid 39233694)
Lund VJ, Black JH, Szabo LZ, et al. Efficacy and tolerability of budesonide aqueous nasal spray in chronic rhinosinusitis patients. Rhinology. 2004;42:57-62. (Pubitemid 38811704)
Patel RS, Shaw RS, Wallace AM, et al. Efficacy and systemic tolerability of mometasone furoate and betamethasone sodium phosphate. J Laryngol Otol. 2004;118:866-71. (Pubitemid 39657144)
Aukema AA, Mulder PG, Fokkens WJ. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone proprionate nasal drops reduces need for sinus surgery. J Allergy Clin Immunol. 2005;115:1017-23. (Pubitemid 40616217)
Damm M, Quante G, Jungehueslsing M, et al. Impact of functional endoscopic sinus surgery on symptoms and quality of life in chronic rhinosinusitis. Laryngoscope. 2002;112:310-5. (Pubitemid 34139785)
Chiu AG, Kennedy DW. Surgical management of chronic rhinosinusitis and nasal polyposis: a review of evidence. Curr Allergy Asthma Rep. 2004;4:486-9. (Pubitemid 39591591)
Iro H, Mayr S, Wallisch C, et al. Endoscopic sinus surgery: its subjective medium-term outcome in chronic rhinosinusitis. Rhinology. 2004;42:200-6. (Pubitemid 39646590)
Dhong HJ, Jung YS, Chung SK, et al. Effect of endoscopic sinus surgery on asthmatic patients with chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2001;124:99-104. (Pubitemid 32096789)
Dunlop G, Scadding GK, Lund VJ. The effect of endoscopic sinus surgery on asthma: management of patients with chronic rhinosinusitis, nasal polyposis and asthma. Am J Rhinol. 1999;13:261-5.
Goldstein MF, Grundfast SK, Dunsky EH, et al. Effect of functional endoscopic sinus surgery on bronchial asthma outcomes. Arch Otolaryngol Head Neck Surg. 1999;125:314-9. (Pubitemid 29133697)
Ikeda K, Tanno N, Tamura G, et al. Endoscopic sinus surgery improves pulmonary function in patients with asthma associated with chronic sinusitis. Ann Otol Rhinol Laryngol. 1999;108:355-9. (Pubitemid 29190148)
Senior BA, Kennedy DW, Tanabodee J, et al. Long-term impact of functional endoscopic sinus surgery on asthma. Otolaryngol Head Neck Surg. 1999;121:66-8. (Pubitemid 29325962)
Jorrissen M, Bachert C. Effect of corticosteroids on wound healing after endoscopic sinus surgery. Rhinology. 2009;47 (3):280-6.
Verbruggen K, Van Cauwenberge P, Bachert C. Anti-IgE for the treatment of allergic rhinitis - and eventually nasal polyps? Int Arch Immunol. 2009;148(2):87-98.
Bachert C, Zhang N, Patou J, van Zele T, Gevaert P. Role of staphylococcal superantigens in upper airway disease. Curr Opin Allergy Clin Immunol. 2008;8(1):34-8.
Gevaert P, Johannson S, Bachert C. Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship. Int Arch Allergy Immunol. 2004;133:255-60. (Pubitemid 38529218)
Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24(5):758-64. (Pubitemid 39504428)
Vignola AM, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V, et al. Airway remodeling in asthma. Chest. 2003;123:417-22.
Coste A, Brugel L, MaöÄtre B, Boussat S, Papon JF, Wingerstmann L, et al. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur Respir J. 2000;15:367-72. (Pubitemid 30085967)
Perez-Novo CA, Kowalski ML, Kuna P, Ptasinska A, Holtappels G, Van Cauwenberge P, et al. Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship. Int Arch Allergy Immunol. 2004;133:255-60. (Pubitemid 38529218)
Bachert C, Wagenmann M, Rudack C, Höpken K, Hillebrandt M, Wang D, et al. The role of cytokines in infectious sinusitis and nasal polyposis. Allergy. 1998;53:2-13. (Pubitemid 28057357)
Bachert C, Gevaert P, Holtappels G, van Cauwenberge P. Mediators in nasal polyposis. Curr Allergy Asthma Rep. 2002;2:481-7.
Nonaka M, Pawankar R, Saji F, et al. Eotaxin synthesis by nasal polyp fibroblasts. Acta Otolaryngol. 1999;119:816-20. (Pubitemid 30070303)
Nonaka M, Pawankar R, Saji F, et al. Distinct expression of RANTES and GM-CSF by lipopolysaccharide in human nasal fibroblasts but not in other airway fibroblasts. Int Arch Allergy Immunol. 1999;119:314-21. (Pubitemid 29401701)
Hans-Uwe S, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol. 1997;158:3902-8. (Pubitemid 127488750)
Chao SS, Graham SM, Brown CL, Kline JN, Hussain I. Cysteinyl leukotriene 1 receptor expression in nasal polyps. Ann Otol Rhinol Laryngol. 2006;115(5):394-7. (Pubitemid 43736852)
Bachert C, Gevaert P, Holtappels G, Johansson SGO, Van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 2001;107:607-14. (Pubitemid 32397745)
Bachert C, Gevaert P, Howarth P, Holtappels G, van Cauwenberge P, Johansson SGO. IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma. J Allergy Clin Immunol. 2003;111:1131-2. (Pubitemid 36570878)
Zhang N, Holtappels G, Claeys C, Huang G, Vancauwenberge P, Bachert C. Pattern of inflammation and impact of Staphylococcus aureus enterotoxins in nasal polyps from southern China. Am J Rhinol. 2006;20(4):445-50. (Pubitemid 44390224)
Bachert C, Watelet JB, Gevaert P, Van Cauwenberge P. Pharmacological management of nasal polyposis. Drugs. 2005;65(11):1537-52. (Pubitemid 41124307)
Assanasen P, Naclerio RM. Medical and surgical management of nasal polyps. Curr Opin Otolaryngol Head Neck Surg. 2001;9:27-36. (Pubitemid 32106097)
Scadding GK. Comparison of medical and surgical treatment of nasal polyposis. Curr Allergy Asthma Rep. 2002;2:494-9.
Hissaria P, Smith W, Wormald PJ, Taylor J, Vadas M, Gillis D, et al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo controlled trial with evaluation of outcome measures. J Allergy Clin Immunol. 2006;118(1):128-33. (Pubitemid 43946470)
Van Camp P, Clement PAR. Results of oral steroid treatment in nasal polyposis. Rhinology. 1994;32:5-9. (Pubitemid 24133848)
Lildholdt T, Rundccrantz H, Bende M, et al. Glucocorticoid treatment for nasal polyps: a study of budesonide powder and depot-steroid injection. Arch Otolaryngol Head Neck Surg. 1997;123:595-600. (Pubitemid 27258448)
Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008;63(10):1292-300.
Holmberg K, Juliusson S, Balder B, et al. Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis. Ann Allergy Asthma Immunol. 1997;78:270-6. (Pubitemid 27142895)
Lund VJ, Flood J, Sykes AP, et al. Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg. 1998;124:513-8. (Pubitemid 28222339)
Lildholt T, Rundcrantz H, Lindqvist N. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebocontrolled study of budesonide. Clin Otolaryngol. 1995;20:26-30.
Lildholdt T, Fogstrup J, Gammelgaard N, et al. Management of nasal polyps by steroid nose drops. Am J Rhinol. 1991;5:1-3.
Penttila M, Poulsen P, Hollingworth K, et al. Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 microgram once daily and twice daily in the treatment of bilateral nasal polyposis: a placebocontrolled randomized study in adult patients. Clin Exp Allergy. 2000;30:94-102. (Pubitemid 30093886)
Gotfried MH. Macrolides for the treatment of chronic sinusitis, asthma and COPD. Chest. 2004;125:52S-61.
Cervin A. The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis. Acta Otolaryngol. 2001;121(1):83-92. (Pubitemid 32205030)
Matsune S, Sun D, Ohori J, Nishimoto K, Fukuiwa T, Ushikai M, et al. Inhibition of vascular endothelial growth factor by macrolides in cultured fibroblasts from nasal polyps. Laryngoscope. 2005;115(11):1953-6. (Pubitemid 44391655)
Yamada T, Fujieda S, Mori S, et al. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol. 2000;14(3):143-8. (Pubitemid 30441214)
Nonaka M, Pawankar R, Tomiyama S, et al. A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts. Am J Rhinol. 1999;13(4):267-72.
Iino Y, Sasaki Y, Kojima C, et al. Effect of macrolides on the expression of HLA-DR and costimulatory molecules on antigen-presenting cells in nasal polyps. Ann Otol Rhinol Laryngol. 2001;110(5):457-63. (Pubitemid 32433859)
Ichimura K, Shimazaki Y, Ishibashi T, et al. Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx. 1996;23:48-56. (Pubitemid 26185193)
Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope. 2006;116:189-93. (Pubitemid 44383921)
Holgate ST, Canonica GW, Simons FER, Taglialatela M, Tharp M, Timmermans H, et al. Consensus group on new-generation antihistamines (CONGA): present status and recommendations. Clin Exp Allergy. 2003;33:1305-24. (Pubitemid 37108537)
Keith PK, Conway M, Evans S, et al. Nasal polyps: effects of seasonal allergen exposure. J Allergy Clin Immunol. 1994;93 (3):567-74. (Pubitemid 24105061)
Crampette L, Mainprice B, Bloom M, et al. Inhibition of mediator and cytokine release from dispersed nasal polyp cells by terfenadine. Allergy. 1996;51(5):346-9. (Pubitemid 26232830)
Campbell A, Michel FB, Bremard-Oury C, et al. Overview of allergic mechanisms: ebastine has more than an antihistamine effect. Drugs. 1996;52 Suppl 1:15-9.
Carayol N, Crampette L, Mainprice B, et al. Inhibition of mediator and cytokine release from dispersed nasal polyp cells, by mizolastine. Allergy. 2002;57(11):1067-70. (Pubitemid 35238646)
Vignola AM, Crampette L, Mondain M, et al. Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells. Allergy. 1995;50(3):200-3.
Haye R, Aanesen JP, Burtin B, et al. The effect of cetirizine on symptoms and signs of nasal polyposis. J Laryngol Otol. 1998;112(11):1042-6. (Pubitemid 28505018)
Alobid I, Cardelus S, Picado C, Mullol J. Antileukotrienes in rhinosinusitis and nasal polyposis. Expert Rev Clin Immunol. 2008;4(3):331-7. (Pubitemid 351903271)
Di Rienzo L, Artuso A, Cerqua N. Antileukotrienes in the prevention of postoperative recurrence of nasal polyposis in ASA syndrome. Acta Otolaryngol Ital. 2000;20(5):336-42.
Stevenson DD, Hankammer MA, Mathison DA, et al. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol. 1996;98(4):751-8. (Pubitemid 26357241)
Stevenson DD. Aspirin desensitization in patients with AERD. Clin Rev Allergy Immunol. 2003;24(2):159-68.
Fiotta N, Altamura N, Moretti M, Wasserman ST, Zacchigna S, Farra R, et al. Short term effects of doxycycline on Matrix Metalloproteinases 2 and 9. Cardiovasc Drugs Ther. 2009;23 (2):153-9.
Van Zele T, Gevaert P, Holtappels G, Beule A, Wormald PJ, Mayr S, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125(5):1069-1076.e4.
Bachert C, Wagenmann M, Hauser U, et al. IL-5 is upregulated in human nasal polyp tissue. J Allergy Clin Immunol. 1997;99 (6):837-42. (Pubitemid 27280376)
Penn R, Mikula S. The role of anti-IgE immunoglobulin therapy in nasal polyposis: a pilot study. Am J Rhinol. 2007;21(4):428-32. (Pubitemid 47360029)
Mendelson MG, Gross CW. Soft-tissue shavers in pediatric sinus surgery. Otolaryngol Clin North Am. 1997;30:443-9. (Pubitemid 27274644)
Setliff R, Parsons D. The "hummer": new instrumentation for functional endoscopic sinus surgery. Am J Rhinol. 1994;8:275-8.
Zweig JL, Schaitkin BM, Fan CY, et al. Histopathology of tissue samples removed using the microdebrider technique: implications for endoscopic sinus surgery. Am J Rhinol. 2000;14:27-32.
Bernstein JM, Lebowitz RA, Jacobs JB. Initial report on postoperative healing after endoscopic sinus surgery with the microdebrider. Otolaryngol Head Neck Surg. 1998;118:800-3. (Pubitemid 28307467)
Kacker A, TabaEE A, Anand V. Computer-assisted surgical navigation in revision endoscopic sinus surgery. Otolaryngol Clin North Am. 2005;38(3):473-82. (Pubitemid 40724834)
Caversaccio M, Zheng G, Nolte LP. Computer-aided surgery of the paranasal sinuses and the anterior skull base. HNO. 2008;56 (4):376-8. 780-2.
Metson RB, Gliklich RE. Clinical outcomes in patients with chronic sinusitis. Laryngoscope. 2000;110 suppl 94:24-8.
Keles N, Ilicali OC, Deger K. Objective and subjective assessment of nasal obstruction in patients undergoing endoscopic sinus surgery. Am J Rhinol. 1998;12:307-9. (Pubitemid 128750986)
Rowe-Jones JM, Mackay IS. A prospective study of olfaction following endoscopic sinus surgery with adjuvant medical treatment. Clin Otolaryngol. 1997;22:377-81. (Pubitemid 28346980)
Hafner B, Davris S, Riechelmann H, et al. Endonasal sinus surgery improves mucociliary transport in severe chronic sinusitis. Am J Rhinol. 1997;11:271-4. (Pubitemid 127773053)
Kaluskar SK. Pre- and postoperative mucociliary clearance in functional endoscopic sinus surgery. Ear Nose Throat J. 1997;76:884-6. (Pubitemid 28040218)
Elwany S, Hisham M, Gamaee R. The effect of endoscopic sinus surgery on mucociliary clearance in patients with chronic sinusitis. Eur Arch Otorhinolaryngol. 1998;255:511-4. (Pubitemid 29004753)
Delak KW, Stoll W. Olfactory function after functional endoscopic sinus surgery for chronic sinusitis. Rhinology. 1998;36:15-9. (Pubitemid 28166208)
Shin SH, Park JY, Sohn JH. Clinical value of olfactory function tests after endoscopic sinus surgery: a short-term result. Am J Rhinol. 1999;13:63-6.
Amar YG, Frenkiel S, Sobol SE. Outcome analysis of endoscopic sinus surgery for chronic sinusitis in patients having Samter's triad. J Otolaryngol. 2000;29:7-12. (Pubitemid 30120552)
Nakamura H, Kawasaki M, Higuchi Y, et al. Effects of sinus surgery on asthma in aspirin triad patients. Acta Otolaryngol. 1999;119:592-8. (Pubitemid 29378953)
Hartwig S, Linden M, Laurent C, et al. Budesonide nasal spray as prophylactic treatment after polypectomy (a double blind clinical trial). J Laryngol Otol. 1988;102(2):148-51. (Pubitemid 18065236)
Virolainen E, Puhakka H. The effect of intranasal beclomethasone dipropionate on the recurrence of nasal polyps after ethmoidectomy. Rhinology. 1980;18(1):9-18. (Pubitemid 10147375)
Stjärne P, Olsson P, Alenius M. Use of mometasone furoate to prevent polyp relapse after endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg. 2009;135(3):296-302.
Rhinosinusitis Task Force Committee. Report of the Rhinosinusitis Task Force Committee Meeting, Alexandria, VA, August 17, 1996. Otolaryngol Head Neck Surg. 1997;117: S1-68.
